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Introduction
Familial Mediterranean fever (FMF) is an inherited autoin-
flammatory disorder characterized by recurring attacks of
fever accompanied by intense pain in the abdomen, chest,
or joints. Colchicine, is an important drug which is used in
diseases such as FMF and acute gout attacks. However, it
has significant side effects such as diarrhea, nausea, vomit-
ing and fatigue. Some of the patients does not respond to
treatment due to resistance. Therefore it is important to
measure the serum levels of colchicine. The expected
serum levels of colchicine is about 5-15 ng/ml. Correct
measurement of this level with the classical analytical
methods are not easy. Phase extraction and sample con-
centration of colchicine in routine laboratory conditions is
time-consuming, so advanced analytical instruments such
as LC-MS/MS and easy sample preparation methods are
needed.
Method
We used Agilent model 6420 LC-MS / MS to measure the
serum level of colchicine. Pimozide was used as an internal
standard and 100 microliters of IS (7.5 ng/ml) was added
into 200 microliters serum. Then serum proteins was pre-
cipitated by 900 microliters of methanol and 20 microliters
of the supernatant was injected into LC-MS/MS. LC flow
rate of 0.5 ml, the phase gradient of 10 mM ammonium
acetate + 0.1% formic acid for phase A and the mixture
consisted of 0.1% formic acid in methanol for phase B
were used.
Results
Calibration curve for colchicine was constructed with
five levels (1.56, 3.1, 6.25, 12.5, 25 ng/ml). r2 value was
found to be 0.999. Peak arrival time of 1.9 minutes, the
accuracy value of 100.44, the recovery value was found
to be 82%. LOD (limit of detection) value was 0.05 ng/ml
and the LOQ was 0.1 ng/mL. We tried different sub-
stances as an internal standard such as caffeine, cotinine,
amlodipine, nifedipine and diltiazem but pimozide was
the more stable and consistent, in addition to the least
possibility of endogenous existince and reproducibility
was found to be the best amongst the others.
Conclusion
We have developed a method for the measurement of col-
chicine using LC-MS/MS facilitated the extraction step,
and can be applied in routine practice. Dose adjustment
may become possible for rational drug use by comparing
the serum concentration in response to different doses of
colchicine. Thus, to avoid the side effects of medication
can be possible with the use of the lowest dose producing
responses to the treatment.
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